Welcome to Central Library, SUST

Antiviral drugs : (Record no. 62729)

MARC details
000 -LEADER
fixed length control field 08214cam a2200841Mi 4500
001 - CONTROL NUMBER
control field sulb-eb0031077
003 - CONTROL NUMBER IDENTIFIER
control field BD-SySUS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20170713221246.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |n|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100616s2011 njua ob 001 0 eng d
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
Canceled/invalid LC control number 2010025372
040 ## - CATALOGING SOURCE
Original cataloging agency CDX
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency CDX
Modifying agency TXA
-- YDXCP
-- E7B
-- N$T
-- EBLCP
-- OCLCQ
-- OCLCF
-- OCLCQ
-- NLGGC
-- OCLCQ
-- MHW
-- UKDOC
-- AU@
-- OCLCQ
-- TMC
-- OCLCQ
-- OCLCO
-- OCL
-- DEBBG
-- D6H
-- AZK
-- BD-SySUS
019 ## -
-- 758982153
-- 770872450
-- 842264613
-- 961519634
-- 962640546
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780470929353
Qualifying information (electronic bk.)
International Standard Book Number 0470929359
Qualifying information (electronic bk.)
International Standard Book Number 9780470929346
Qualifying information (electronic bk.)
International Standard Book Number 0470929340
Qualifying information (electronic bk.)
Canceled/invalid ISBN 9780470455630
Qualifying information (Cloth)
Canceled/invalid ISBN 0470455632
Qualifying information (Cloth)
Canceled/invalid ISBN 9780470934685
Canceled/invalid ISBN 0470934689
024 8# - OTHER STANDARD IDENTIFIER
Standard number or code 9786613203632
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier AU@
System control number 000047773982
OCLC library identifier AU@
System control number 000050894470
OCLC library identifier DKDLA
System control number 820120-katalog:000573080
OCLC library identifier NZ1
System control number 15915097
OCLC library identifier DEBBG
System control number BV043393434
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)746598445
Canceled/invalid control number (OCoLC)758982153
-- (OCoLC)770872450
-- (OCoLC)842264613
-- (OCoLC)961519634
-- (OCoLC)962640546
037 ## - SOURCE OF ACQUISITION
Stock number 320363
Source of stock number/acquisition MIL
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM411
Item number .A5753 2011eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 268.5
Item number A63347 2011
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615/.7924
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Antiviral drugs :
Remainder of title from basic discovery through clinical trials /
Statement of responsibility, etc. edited by Wieslaw M. Kazmierski.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hoboken, N.J. :
Name of producer, publisher, distributor, manufacturer Wiley,
Date of production, publication, distribution, manufacture, or copyright notice ©2011.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xiii, 438 pages) :
Other physical details illustrations (some color)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type data file
Source rda
380 ## - FORM OF WORK
Form of work Bibliography
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Frontmatter -- Color Plates -- Human Immunodeficiency Virus. Discovery and Development of Atazanavir / Awny Farajallah, R Todd Bunch, Nicholas A Meanwell -- Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor / Jinzi J Wu, Joseph Musto -- Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients / Marie-Pierre de B̌thune, Vanitha Sekar, Sabrina Spinosa-Guzman, Marc Vanstockem, Sandra De Meyer, Piet Wigerinck, Eric Lefebvre -- Discovery and Development of Tipranavir / Karen R Romines -- TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients / Jerome Guillemont, Katia Boven, Herta Crauwels, Marie-Pierre de B̌thune -- Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients / Koen Andries, Ann Debunne, Thomas N Kakuda, Michael Kukla, Ruud Leemans, Johan Vingerhoets, Brian Woodfall, Marie-Pierre de B̌thune -- Discovery and Development of Tenofovir Disoproxil Fumarate / Erik De Clercq -- Discovery and Development of Apricitabine / Susan Cox, John Deadman, Justine Southby, Jonathan Coates -- Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection / Patrick Dorr, Paul Stupple -- Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection / Jayaram R Tagat, Julie M Strizki, Lisa M Dunkle -- Discovery and Development of HIV-1 Entry Inhibitors That Target gp120 / John F Kadow, John Bender, Alicia Regueiro-Ren, Yasutsugu Ueda, Tao Wang, Kap-Sun Yeung, Nicholas A Meanwell -- Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation / Melissa S Egbertson, John S Wai, Mark Cameron, R Scott Hoerrner -- Discovery and Development of HIV Integrase Inhibitor Raltegravir / Vincenzo Summa, Paola Pace -- Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer Inhibitor / Hisashi Shinkai, Masanori Sato, Yuji Matsuzaki -- Hepatitis C Virus. Discovery and Development of Telaprevir / Anne-Laure Grillot, Luc J Farmer, B Govinda Rao, William P Taylor, Ilan S Weisberg, Ira M Jacobson, Robert B Perni, Ann D Kwong -- Discovery and Development of BILN 2061 and Follow-Up BI 201335 / Montse Llin̉s-Brunet, Peter W White -- Intervention of Hepatitis C Replication through NS3-4A, the Protease Inhibitor Boceprevir / Srikanth Venkatraman, F George Njoroge -- Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227) / Scott D Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu, Brad O Buckman -- Discovery and Development of the HCV Protease Inhibitor TMC435 / Pierre Raboisson, Gregory Fanning, Herman de Kock, Asa Rosenquist, Rene Verloes, Kenneth Simmen -- Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection / Klaus Klumpp, David B Smith -- Discovery and Development of PSI-6130/RG7128 / Phillip A Furman, Michael J Otto, Michael J Sofia -- Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV / Kai Lin -- HCV Viral Entry Inhibitors / Flossie Wong-Staal, Guohong Liu, Jeffrey McKelvy -- Respiratory Syncytial Virus Inhibitors. Discovery of the RSV Inhibitor TMC353121 / Jean-Fraṅois Bonfanti, Gabriela Ispas, Frans Van Velsen, Wieslawa Olszewska, Tom Gevers, Dirk Roymans -- Discovery and Development of Orally Active RSV Fusion Inhibitors / Nicholas A Meanwell, Christopher W Cianci, Mark R Krystal -- Discovery and Development of RSV604 / Joanna Chapman, Stuart Cockerill -- Influenza, Hepatitis B, and Cytomegalovirus Inhibitors. Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza / Robin Thomson, Mark von Itzstein -- Discovery and Development of Entecavir / Richard Wilber, Bruce Kreter, Marc Bifano, Stephanie Danetz, Lois Lehman-McKeeman, Daniel J Tenney, Nicholas Meanwell, Robert Zahler, Helena Brett-Smith -- Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus Diseases / Karen K Biron, Kristjan S Gudmundsson, John C Drach -- Index.
520 ## - SUMMARY, ETC.
Summary, etc. This book focuses on new small molecule approaches to combat viral infections. The chapters describe the discovery and development from bench through the clinic of relatively recently-approved antiviral drugs and compounds in advanced clinical development. Organized by a virus (such as HIV, HCV, RSV, influenza, HBV and CMV) and written by top academic and industrial authorities in the field, the book provides a unique opportunity to study, understand and apply discovery and development principles and learning without the need for an individual to research, analyze and synthesize all immense sourcing references. Topics showcase challenges and solutions of issues encountered, offering tremendous experience accumulated over many years of research that will be particularly useful to basic and bench scientists as well as clinicians as they continue discovering and developing new drugs and therapies.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antiviral agents.
Topical term or geographic name as entry element Clinical trials.
Topical term or geographic name as entry element Antiviral Agents
General subdivision therapeutic use.
Topical term or geographic name as entry element Antiviral agents.
Topical term or geographic name as entry element Drug Evaluation.
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
Topical term or geographic name as entry element Clinical trials
Source of heading or term fast
Authority record control number (OCoLC)fst00864429
Topical term or geographic name as entry element Antiviral agents.
Source of heading or term fast
Authority record control number (OCoLC)fst00810869
Topical term or geographic name as entry element Antiviral Agents
General subdivision therapeutic use.
Topical term or geographic name as entry element Clinical Trials as Topic.
Topical term or geographic name as entry element Drug Discovery.
Topical term or geographic name as entry element Drug Evaluation.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kazmierski, Wieslaw M.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
International Standard Book Number 9786613203632
Record control number (DLC) 2010025372
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://onlinelibrary.wiley.com/book/10.1002/9780470929353">http://onlinelibrary.wiley.com/book/10.1002/9780470929353</a>
Public note Wiley Online Library [Free Download only for SUST IP]
938 ## -
-- 123Library
-- 123L
-- 19611
-- Coutts Information Services
-- COUT
-- 18349244
-- 0.00 GBP
-- EBL - Ebook Library
-- EBLB
-- EBL818637
-- ebrary
-- EBRY
-- ebr10490613
-- EBSCOhost
-- EBSC
-- 390121
-- YBP Library Services
-- YANK
-- 7503700
-- YBP Library Services
-- YANK
-- 3350592
-- YBP Library Services
-- YANK
-- 3537696
994 ## -
-- 92
-- DG1

No items available.